Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin F Fromm

Showing results (61-70 of 187) with videos related to

Pageof 19
Sort By:
Biochemical and Biophysical Research Communications|September 11, 2008
Activation of negative regulators of the hypoxia-inducible factor (HIF) pathway in human end-stage heart failureOliver Zolk, Thomas F Solbach, Thomas Eschenhagen, et al.
Molecular Genetics and Genomics : MGG|November 9, 2007
Non-synonymous polymorphisms in the human SLCO1B1 gene: an in vitro analysis of SNP c.1929A>CAnnick Seithel, Kathrin Klein, Ulrich M Zanger, et al.
Cellular & Molecular Biology Letters|June 3, 2026
Deorphanisation and functional characterisation of OATP5A1 as transport protein for amino acids and vitaminsElena Kohlmann, Nikola K Schmid, Arne Gessner, et al.
Plos One|December 5, 2024
Medication safety with oral antitumour therapeutics in paediatrics (youngAMBORA): A mixed-methods approach towards a tailored care programPhyllis Lensker, Lisa Cuba, Katja Gessner, et al.
Biomedical Chromatography : BMC|May 28, 2005
Simultaneous determination of oxycodone and its major metabolite, noroxycodone, in human plasma by high-performance liquid chromatographyOlga Cheremina, Iouri Bachmakov, Antje Neubert, et al.
Clinical Pharmacology and Therapeutics|May 9, 2022
Renal Transporter-Mediated Drug-Biomarker Interactions of the Endogenous Substrates Creatinine and N<sup>1</sup> -Methylnicotinamide: A PBPK Modeling ApproachDenise Türk, Fabian Müller, Martin F Fromm, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 8, 2012
Inhibition of hepatic uptake transporters by flavonoidsKathrin Mandery, Bettina Balk, Krystyna Bujok, et al.
Applied Clinical Informatics|July 31, 2024
Interprofessional Evaluation of a Medication Clinical Decision Support System Prior to ImplementationJacqueline Bauer, Marika Busse, Tanja Kopetzky, et al.
Clinical Pharmacology and Therapeutics|August 2, 2003
Celecoxib inhibits metabolism of cytochrome P450 2D6 substrate metoprolol in humansUlrike Werner, Dierk Werner, Thomas Rau, et al.
European Journal of Clinical Pharmacology|September 6, 2007
Impact of the CYP3A5 genotype on midazolam pharmacokinetics and pharmacodynamics during intensive care sedationMartin F Fromm, Helmut Schwilden, Iouri Bachmakov, et al.
Pageof 19

Showing results (61-70 of 187) with videos related to

Sort By:
Pageof 19
Biochemical and Biophysical Research Communications|September 11, 2008
Activation of negative regulators of the hypoxia-inducible factor (HIF) pathway in human end-stage heart failureOliver Zolk, Thomas F Solbach, Thomas Eschenhagen, et al.
Molecular Genetics and Genomics : MGG|November 9, 2007
Non-synonymous polymorphisms in the human SLCO1B1 gene: an in vitro analysis of SNP c.1929A>CAnnick Seithel, Kathrin Klein, Ulrich M Zanger, et al.
Cellular & Molecular Biology Letters|June 3, 2026
Deorphanisation and functional characterisation of OATP5A1 as transport protein for amino acids and vitaminsElena Kohlmann, Nikola K Schmid, Arne Gessner, et al.
Plos One|December 5, 2024
Medication safety with oral antitumour therapeutics in paediatrics (youngAMBORA): A mixed-methods approach towards a tailored care programPhyllis Lensker, Lisa Cuba, Katja Gessner, et al.
Biomedical Chromatography : BMC|May 28, 2005
Simultaneous determination of oxycodone and its major metabolite, noroxycodone, in human plasma by high-performance liquid chromatographyOlga Cheremina, Iouri Bachmakov, Antje Neubert, et al.
Clinical Pharmacology and Therapeutics|May 9, 2022
Renal Transporter-Mediated Drug-Biomarker Interactions of the Endogenous Substrates Creatinine and N<sup>1</sup> -Methylnicotinamide: A PBPK Modeling ApproachDenise Türk, Fabian Müller, Martin F Fromm, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 8, 2012
Inhibition of hepatic uptake transporters by flavonoidsKathrin Mandery, Bettina Balk, Krystyna Bujok, et al.
Applied Clinical Informatics|July 31, 2024
Interprofessional Evaluation of a Medication Clinical Decision Support System Prior to ImplementationJacqueline Bauer, Marika Busse, Tanja Kopetzky, et al.
Clinical Pharmacology and Therapeutics|August 2, 2003
Celecoxib inhibits metabolism of cytochrome P450 2D6 substrate metoprolol in humansUlrike Werner, Dierk Werner, Thomas Rau, et al.
European Journal of Clinical Pharmacology|September 6, 2007
Impact of the CYP3A5 genotype on midazolam pharmacokinetics and pharmacodynamics during intensive care sedationMartin F Fromm, Helmut Schwilden, Iouri Bachmakov, et al.
Pageof 19